Ignite Creation Date:
2025-12-24 @ 2:30 PM
Ignite Modification Date:
2026-04-02 @ 4:43 AM
Study NCT ID:
NCT00551759
Status:
TERMINATED
Last Update Posted:
2023-07-03
First Post:
2007-10-30
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer
Sponsor:
Eastern Cooperative Oncology Group
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-10-02
Start Date Type:
ACTUAL
Primary Completion Date:
2011-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-02
Completion Date Type:
ACTUAL
First Submit Date:
2007-10-30
First Submit QC Date:
None
Study First Post Date:
2007-10-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-01-17
Results First Submit QC Date:
None
Results First Post Date:
2014-02-28
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-14
Last Update Post Date:
2023-07-03
Last Update Post Date Type:
ACTUAL